Optimum Video Q&A: Getting to know Renee Aguiar-Lucander

Since taking over as CEO of Calliditas Therapeutics in 2017, Renee Aguiar-Lucander has taken the biotech through an IPO in Stockholm and commenced a pivotal phase 3 trial plus major licensing deals and a secondary fund raise.  She has established a US presence, made transformational regulatory milestones, and this month completed a successful upsized US […]

Sounding out experts on new treatments for the silent epidemic of COPD

Are you sitting comfortably? Do you notice your breathing, all nice and easy? Now, try taking a straw and breathing just through that. Not quite so easy is it?

Applications for BaseLaunch Phase II accelerator program to close on 22nd June

This is a fantastic initiative that helps young businesses by providing the support they need to succeed. This includes up to USD 500,000 in fundraising, introduction to a dynamic network and access to free lab space.

Natural Killer Cells from Universal Donors

Has Kiadis Found Immunotherapy’s Killer App? In Amsterdam, there has just been a glimpse of the future of cellular medicine.

Optimum European Healthcare Investor Survey

European investors continue actively investing in healthcare. The survey held in May 2020 includes responses from 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector.

© Optimum Strategic Communications.